Dr. Gallacher offers Xeomin, a cosmetic injection that addresses moderate to severe frown lines, crow’s feet, forehead wrinkles, and frown lines or “11’s” formed between the eyes.
How Does Xeomin Work?
As with Botox and Dysport, Dr. Gallacher injects Xeomin’s neurotoxins into specific areas. The injection paralyzes the muscles that cause wrinkles. The results are smooth, youthful brows and evened skin. Xeomin contains no additives, just the botulinum toxin type A. This pure approach to the filler prevents patients from developing antibodies against Xeomin. It also makes clients less likely to experience allergic reaction from a Xeomin treatment.
Full effects of Xeomin injections occurs within one week and last from three to six months. This onset and duration is comparable to the effects of Botox.
Is Xeomin for Me?
Xeomin helps adults over twenty-one years old who are plagued by moderate to severe wrinkles between the eyebrows, throughout the forehead, or alongside the eyes. You should discuss other neurotoxin injections or dermatological treatments with Dr. Gallacher during your consultation. Xeomin treatments result in immediately smoother skin, and results last from three to six months.
Is Xeomin Safe?
In July, 2011, the FDA approved the newest botulinum toxin type A injection, Xeomin for adult cosmetic purposes. Manufactured by Merz Pharmaceuticals, this Botox alternative has been used to treat more than 84,000 people world-wide.
What are the Side Effects of Xeomin?
All botulinum products carry an FDA warning because of the risk of botulinum toxin spreading from the injection area. If spread, botulinum can cause life-threatening swallowing and breathing problems.
As with any injection, clients should watch for allergic reactions. Other risks include bleeding and bruising at injection sites, itching, swelling, and shortness of breath. Dr. Gallacher discusses all risks with patients during consultation.
Rare side effects include neck pain, muscle weakness, and musculoskeletal pain. Headache, impaired vision, and upper respiratory infections occur in rare instances.